Hospital
Iasis Glenwood Regional Medical Center LP
Iasis Glenwood Regional Medical Center LP was paid $15.31M by Medicaid between Jan 2018 and Nov 2024, across 141 billing codes. Its largest line is 99284, emergency room visit (serious) — 25% of everything it billed.
33Billing provider infoIASIS GLENWOOD REGIONAL MEDICAL CENTER LP
WEST MONROE, LA 71291
WEST MONROE, LA 71291
33aNPI1487706214assigned 01/18/2007
33bProvider typeGeneral Acute Care Hospital
28Total paid$15.31M
24GClaims421,233
24DCodes billed141
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Louisiana
Rank by total paid#29 of 96
Median peer was paid$5.17M
This provider vs. median3.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 49,514 | $1.25M | |
| 2019 | 46,628 | $1.45M | |
| 2020 | 39,077 | $1.28M | |
| 2021 | 60,700 | $2.08M | |
| 2022 | 84,372 | $3.34M | |
| 2023 | 93,799 | $3.75M | |
| 2024incomplete | 47,143 | $2.17M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 25% | 26,107 | 23,460 | $3.87M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 22% | 20,765 | 17,959 | $3.37M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 19% | 29,123 | 26,671 | $2.87M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.0% | 2,794 | 2,451 | $618K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.8% | 17,157 | 14,588 | $587K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 3.0% | 4,019 | 3,464 | $464K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.8% | 9,594 | 8,276 | $434K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.3% | 5,668 | 4,984 | $345K |
| 71045 | Radiologic examination, chest; single view | 1.8% | 13,411 | 11,818 | $280K |
| 80053 | Comprehensive metabolic panel | 1.3% | 28,239 | 24,536 | $206K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 27,770 | 24,051 | $149K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 2,719 | 2,532 | $126K |
129 more codes
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 3,820 | $109K |
| 83880 | <1% | 4,446 | $108K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 2,188 | $105K |
| 84484 | <1% | 11,897 | $103K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,142 | $97K |
| 99460 | <1% | 2,142 | $88K | |
| 80050 | General health panel | <1% | 2,182 | $82K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 1,170 | $80K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 5,971 | $78K |
| 36415 | Collection of venous blood by venipuncture | <1% | 35,563 | $70K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,667 | $51K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 355 | $50K |
| 74022 | <1% | 1,083 | $47K | |
| 81025 | <1% | 7,273 | $47K | |
| G0378 | Hospital observation service, per hour | <1% | 866 | $46K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,146 | $44K |
| 83690 | <1% | 7,903 | $40K | |
| 58558 | <1% | 211 | $37K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 5,813 | $35K |
| 81001 | <1% | 16,179 | $34K | |
| 74018 | <1% | 1,143 | $33K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,151 | $33K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 5,477 | $32K |
| 87400 | <1% | 2,613 | $31K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 524 | $29K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,768 | $28K |
| 85730 | <1% | 6,242 | $23K | |
| 85610 | <1% | 8,178 | $23K | |
| 49320 | <1% | 105 | $22K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 66 | $20K |
| 00840 | <1% | 178 | $20K | |
| 80143 | <1% | 1,748 | $19K | |
| 87081 | <1% | 2,980 | $18K | |
| 80179 | <1% | 1,662 | $18K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 499 | $16K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 4,560 | $16K |
| 87088 | <1% | 2,432 | $15K | |
| 85379 | <1% | 2,156 | $15K | |
| 82550 | <1% | 3,279 | $14K | |
| 87040 | <1% | 1,805 | $14K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 9,880 | $14K |
| 82150 | <1% | 2,675 | $13K | |
| 82077 | <1% | 1,164 | $12K | |
| 84703 | <1% | 1,758 | $11K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 173 | $10K |
| 81003 | <1% | 6,752 | $10K | |
| 99462 | <1% | 454 | $10K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 4,004 | $9K |
| 73562 | <1% | 112 | $8K | |
| 83605 | <1% | 823 | $7K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 812 | $6K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 493 | $5K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 5,307 | $5K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 48 | $5K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 206 | $5K |
| 82553 | <1% | 657 | $5K | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | <1% | 26 | $4K |
| 73130 | <1% | 52 | $4K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 8,568 | $4K |
| 80320 | <1% | 2,900 | $4K | |
| 85027 | <1% | 800 | $3K | |
| 00811 | <1% | 38 | $3K | |
| 80061 | Lipid panel | <1% | 262 | $3K |
| 83735 | <1% | 637 | $3K | |
| 70486 | <1% | 12 | $3K | |
| 87186 | <1% | 384 | $2K | |
| 73630 | <1% | 27 | $2K | |
| 84439 | <1% | 359 | $2K | |
| 87077 | <1% | 323 | $2K | |
| 00731 | <1% | 44 | $2K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 127 | $2K |
| 87420 | <1% | 126 | $2K | |
| 76536 | <1% | 27 | $2K | |
| 82607 | <1% | 125 | $1K | |
| 00120 | <1% | 12 | $1K | |
| 80329 | <1% | 234 | $1K | |
| 70220 | <1% | 32 | $1K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 17 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 124 | $1K |
| 87807 | <1% | 100 | $1K | |
| 82746 | <1% | 99 | $1K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 525 | $994.55 |
| 84702 | <1% | 138 | $978.25 | |
| 73610 | <1% | 13 | $974.51 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,340 | $963.20 |
| 85007 | <1% | 459 | $931.67 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 61 | $902.67 |
| 90715 | <1% | 71 | $846.35 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 34 | $800.00 |
| 83525 | <1% | 68 | $754.38 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 89 | $687.80 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 478 | $590.70 |
| 59025 | Fetal non-stress test | <1% | 27 | $552.72 |
| 85652 | <1% | 257 | $532.66 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,207 | $510.34 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 493 | $468.11 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,137 | $391.99 |
| 31000 | <1% | 16 | $302.44 | |
| J2704 | Injection, propofol, 10 mg | <1% | 2,273 | $267.24 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 21 | $93.66 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 21 | $74.62 |
| 86140 | <1% | 15 | $69.23 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 427 | $59.58 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,658 | $57.72 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,526 | $50.89 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 201 | $50.74 |
| 99152 | <1% | 19 | $37.17 | |
| 86901 | <1% | 76 | $32.89 | |
| 86900 | <1% | 76 | $32.89 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 43 | $14.24 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 941 | $5.36 |
| A9270 | Non-covered item or service | 0% | 761 | $0.00 |
| 96361 | Intravenous infusion, hydration; each additional hour | 0% | 179 | $0.00 |
| C2617 | Stent, non-coronary, temporary, without delivery system | 0% | 15 | $0.00 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 0% | 91 | $0.00 |
| 00000 | 0% | 303 | $0.00 | |
| C1769 | Guide wire | 0% | 99 | $0.00 |
| 88304 | 0% | 25 | $0.00 | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 0% | 139 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 40 | $0.00 |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 0% | 130 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 45 | $0.00 |
| 90834 | Psychotherapy session, about 45 minutes | 0% | 63 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 15 | $0.00 |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 0% | 1,774 | $0.00 |
| J1956 | Injection, levofloxacin, 250 mg | 0% | 70 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 15 | $0.00 |
| L8613 | Ossicula implant | 0% | 13 | $0.00 |
| A6402 | Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | 0% | 24 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTINNERELLO, JEREMY (HOSPITAL CEO)
| Provider | Location | Paid |
|---|---|---|
| Iasis Glenwood Regional Medical Center LP | West Monroe, LA | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.